Annals of Surgical Oncology

Annals of Surgical Oncology is the official journal of the Society of Surgical Oncology, published by Springer, established in 1994 and devoted to clinical and translational cancer research in surgery, with a 2025 impact factor of 3.8（Annals of Surgical Oncology）是（Society of Surgical Oncology）的官方期刊，由 Springer 出版，创刊于 1994 年，专注外科领域的临床与转化肿瘤研究，2025 年影响因子为 3.8。

Scope

• Disseminating high-quality clinical and translational cancer research, reviews and expert commentary in surgical oncology传播外科肿瘤学领域高质量的临床与转化肿瘤研究、综述与专家评论。
• Advancing the profession of surgical oncology and promoting high-quality multidisciplinary patient care worldwide推动外科肿瘤学专业发展，促进全球高质量的多学科患者照护。
• Improving global cancer surgery education and training and promoting diversity across all of its activities改进全球肿瘤外科教育与培训，并在各项工作中促进多样性。
• Publishing original articles, invited and unsolicited review articles and expert opinion, with particular emphasis on the Landmark Article Series发表原创论文、约稿与自由来稿综述及专家观点，尤以（The Landmark Series）系列为特色。
• Original research articles are limited to a 3,500-word body and no more than seven figures and tables combined原创研究正文限 3,500 词以内，图与表合计不超过 7 个。

History

• The journal was established in 1994, its name chosen at the Society of Surgical Oncology executive council meeting of October 1992该刊创刊于 1994 年，刊名于 1992 年 10 月（Society of Surgical Oncology）执行理事会上确定。
• Charles Balch was appointed founding editor-in-chief, with Donald Morton and Edward Copeland III as associate editors创刊主编为 Charles Balch，Donald Morton 与 Edward Copeland III 任副编辑。
• It is published by Springer on behalf of the Society of Surgical Oncology and has appeared thirteen times a year该刊由 Springer 代（Society of Surgical Oncology）出版，每年发行十三期。
• Its impact factor was 3.5 in 2024 and 3.8 in 2025影响因子 2024 年为 3.5，2025 年为 3.8。

Editors

• The editor-in-chief is Kelly M. McMasters, with Mark S. Roh as executive editor现任主编为 Kelly M. McMasters，Mark S. Roh 任执行编辑。
• Associate editors include Syed A. Ahmad, Kelly K. Hunt, Lisa Newman and Mitchell C. Posner副编辑包括 Syed A. Ahmad、Kelly K. Hunt、Lisa Newman 与 Mitchell C. Posner。
• The editorial board draws surgical oncologists from the United States and further afield编委会汇集来自美国及其他地区的外科肿瘤学家。
• All manuscripts undergo peer review, and the decision of the editor-in-chief and executive editor is final所有稿件均经同行评审，主编与执行编辑的决定为最终结果。